These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11572320)

  • 1. Clinical testing results and high patient satisfaction with a new needle-free device for growth hormone in young children.
    Silverstein JH; Murray FT; Malasanos T; Myers S; Johnson SB; Frye K; Grossman M
    Endocrine; 2001 Jun; 15(1):15-7. PubMed ID: 11572320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
    Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
    Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.
    Iwanaga M; Kamoi K
    Diabetes Technol Ther; 2009 Feb; 11(2):81-6. PubMed ID: 19848573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
    Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus.
    Schipper C; Musholt P; Niemeyer M; Qvist M; Löffler A; Forst T; Pfützner A
    Curr Med Res Opin; 2012 Aug; 28(8):1297-303. PubMed ID: 22746353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label acceptability study of Norditropin SimpleXx--a new liquid growth hormone formulation.
    Stanhope R; Buchanan C; Butler G; Costigan C; Dunger D; Greene S; Hoey H; Hughes I; Kelnar C; Kirk J; Komulainen J; Lowry M; Warner J
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):735-40. PubMed ID: 11453523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with insulin and growth hormone in 17 patients with type-1 diabetes and growth disorders.
    Zucchini S; Iafusco D; Vannelli S; Rabbone I; Salzano G; Pozzobon G; Maghnie M; Cherubini V; Bizzarri C; Bonfanti R; D'Annunzio G; Lenzi L; Maggio MC; Marigliano M; Scaramuzza A; Tumini S; Iughetti L
    Horm Res Paediatr; 2014; 82(1):53-8. PubMed ID: 24925520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User trial of Easypod, an electronic autoinjector for growth hormone.
    Tauber M; Payen C; Cartault A; Jouret B; Edouard T; Roger D
    Ann Endocrinol (Paris); 2008 Dec; 69(6):511-6. PubMed ID: 18589398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.
    Jaber A; Bozzato GB; Vedrine L; Prais WA; Berube J; Laurent PE
    BMC Neurol; 2008 Oct; 8():38. PubMed ID: 18845005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses.
    Campos C; Lajara R; Deluzio T
    Expert Opin Pharmacother; 2012 Sep; 13(13):1837-46. PubMed ID: 22873943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth.
    Desrosiers P; O'Brien F; Blethen S
    Pediatr Endocrinol Rev; 2005 Feb; 2 Suppl 3():327-31. PubMed ID: 16456500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.